To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.

Bill: 118-hr-6400
Sponsor: full_name: Rep. Cárdenas, Tony [D-CA-29]
Introduced: 2023-11-14
Policy area: Health
Subjects: Medicare

Prescription drugs
Latest action: action_date: 2024-12-17
text: Referred to the Subcommittee on Health.

Summaries:

tv_txt: I 118th CONGRESS 1st Session H. R. 6400 IN THE HOUSE OF REPRESENTATIVES November 14, 2023 Mr. Cárdenas introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.

1. Extending eligibility for certain payment increases for biosimilar biological products under the Medicare program Section 1847A(b)(8)(B)(ii)(II) of the Social Security Act (42 U.S.C. 1395w–3a(b)(8)(B)(ii)(II)) is amended by striking 2027 and inserting 2032 .